GoodRx Holdings, Inc., a leading player in the healthcare technology sector, is headquartered in the United States. Founded in 2011, the company has revolutionised the way consumers access prescription medications by providing price transparency and savings options. GoodRx's core offerings include a user-friendly platform that allows users to compare drug prices at local pharmacies, access discounts, and find affordable healthcare services. With a strong market position, GoodRx has garnered millions of users, making it a trusted resource for prescription savings. The company’s unique approach combines technology with healthcare, enabling consumers to make informed decisions about their medications. As a pioneer in the digital health space, GoodRx continues to expand its services, aiming to improve affordability and accessibility in the pharmaceutical industry.
How does GoodRx Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
GoodRx Holdings, Inc.'s score of 17 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
GoodRx Holdings, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and climate commitments suggests that GoodRx may not yet have established a formal framework for addressing its carbon footprint or engaging in sustainability initiatives. As the company operates within a growing industry increasingly focused on environmental responsibility, it may benefit from developing and communicating clear climate strategies in the future.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
GoodRx Holdings, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
